Clinical Trials Browser

Interventional × Lung Neoplasms × Sunitinib × Clear all

NCT02465060 2026-04-13

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Phase 2 Active not recruiting

6,452 enrolled 2 FDA

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmPlasma cellThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Lung Neoplasms, Lymphoma, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT01829217 2018-10-31

Sunitinib in Never-Smokers With Lung Adenocarcinoma

Phase 2 Completed

13 enrolled 5 charts

Lung Neoplasms

NCT00748163 2018-08-08

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00953459 2018-07-26

Sunitinib Malate in Treating Patients With Small Cell Lung Cancer

Phase 2 Terminated

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01402089 2016-02-02

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Phase 4 Completed

GastrointestinalGenitourinarySarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Lung Neoplasms, Gastrointestinal Stromal Tumors

NCT00620347 2013-06-19

Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer

Phase 2 Completed

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01850147 2013-05-09

Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00430261 2010-10-06

Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma

Phase 2 Completed

Adenocarcinoma, Adenocarcinoma, Bronchiolo-Alveolar, Lung Neoplasms

NCT00113516 2010-05-18

A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

Phase 2 Completed

84 enrolled 40 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00712504 2008-11-11

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms